A partnership between The Ohio State University and telemedicine company Teladoc Health will allow some patients living with Type 2 diabetes to access Teladoc’s chronic disease management platform Livongo for free.
Livongo is a personalized health platform designed to help better understand and manage patients' blood sugar, develop better lifestyle habits and improve glycemic control.
“With the prevalence of diabetes growing nationwide and in Ohio, patients are faced with ever-increasing challenges to manage this disease,” Dr. Hal Paz, executive vice president and chancellor for Health Affairs at Ohio State University and CEO of the Ohio State Wexner Medical Center, said in a statement. “This partnership with Teladoc Health’s Livongo disease management and chronic care unit is a complementary platform to deliver high quality care to our patients living with diabetes while advancing our commitment to digital health and innovation.”
Livongo offers users a variety of tools to help patients control their HbA1c and gain better glycemic control. Users can receive real-time feedback and health reminders, access educational material and participate in 5-day health challenges.
“As the number of adults living with diabetes continues to rise around the world, it becomes more and more important to create a new kind of healthcare experience, one that empowers people everywhere to live their healthiest life,” said Joseph DeVivo, president of hospital and health system at Teladoc Health.
Enrollees in the program will also get access to free supplies, including a cellular connected blood glucose meter; unlimited test strips; and ongoing access to Teladoc’s telehealth services and professionals for personalized care.
